54119-38-9

Upstream product

• 6745-75-1 2,5-dimethyl-p-anisaldehyde 
• 75-16-1 methylmagnesium bromide 
• 104174-28-9 1-(4-methoxy-2,5-dimethylphenyl)ethanone 

Downstream Products

• 1343411-25-5 (E)-1-(4-methoxy-2,5-dimethylphenyl)ethanone-propyloxime 
• 1343411-26-6 (E)-1-(4-hydroxy-2,5-dimethylphenyl)ethanone propyloxime 
• 159918-55-5 (E)-methyl 2-(2-((2,5-dimethyl-4-((E)-1-(propoxyimino)ethyl)phenoxy)methyl)-phenyl)-3-methoxyacrylate 
• 1343411-23-3 (E)-1-(4-methoxy-2,5-dimethylphenyl)ethanone oxime 
• 1335395-84-0 C₂₁H₃₁NO₂ 
• 54119-40-3 2,5-Dimethyl-4-methoxystyren 

Relevant academic research and scientific papers

ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

The present invention relates to an alpha-arylmethoxyacrylate derivative, a preparation method thereof and a pharmaceutical composition comprising the same, and the alpha-arylmethoxyacrylate derivative is inhibitory of HIF, which plays an important role in the regulation of genes associated with energy metabolism, vasomotion, angiogenesis and apoptosis and in the response of cells under hypoxic conditions, so that it can be used for preventing or treating of diseases such as cancer, arthritis, psoriasis, diabetic retinopathy and macular degeneration.

Phenylethanol derivatives as triplet sensitizers for 1-azidoadamantane

Laser flash photolysis, phosphorescence and density functional calculations were used to characterize the triplet excited states of phenylethanol derivatives 1, 2, 3 and 4. In acetonitrile, the triplet excited states of these alcohols were formed with rat